← 返回

GZMK(high) CD8(+) T 效应记忆细胞与非转移性结直肠肿瘤中 CD15(high) 中性粒细胞丰度相关,并预测不良临床结局

英文原题:GZMK(high) CD8(+) T effector memory cells are associated with CD15(high) neutrophil abundance in non-metastatic colorectal tumors and predict poor clinical outcome.

查看英文原题

GZMK(high) CD8(+) T effector memory cells are associated with CD15(high) neutrophil abundance in non-metastatic colorectal tumors and predict poor clinical outcome.

PubMed 2022/11/08(内容时间) Nat Commun Q1 · IF 18.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

CD8+ T细胞是包括结直肠癌(CRC)在内的实体瘤的主要预后决定因素。然而,不同免疫细胞之间的相互作用如何影响临床结局,目前仍处于起步阶段。在此,我们描述了表达高水平CD15的肿瘤浸润中性粒细胞与CD8+ T效应记忆细胞(TEM)之间的相互作用与肿瘤进展相关。在机制上,基质细胞衍生因子-1(CXCL12/SDF-1)促进中性粒细胞在肿瘤内的滞留,增加其与CD8+ T细胞的串扰。由于与中性粒细胞的接触介导的相互作用,CD8+ T细胞偏向于产生高水平GZMK,进而降低肠上皮上的E-钙黏蛋白并促进肿瘤进展。总体而言,我们的结果突显了在非转移性CRC肿瘤中出现GZMK高表达CD8+ TEM,这是由与中性粒细胞相互作用驱动的一个标志,可用于改进当前的患者分层并成为新疗法的靶点。

展开英文摘要原文

CD8 + T cells are a major prognostic determinant in solid tumors, including colorectal cancer (CRC).

However, understanding how the interplay between different immune cells impacts on clinical outcome is still in its infancy.

Here, we describe that the interaction of tumor infiltrating neutrophils expressing high levels of CD15 with CD8 + T effector memory cells (T EM ) correlates with tumor progression.

Mechanistically, stromal cell-derived factor-1 (CXCL12/SDF-1) promotes the retention of neutrophils within tumors, increasing the crosstalk with CD8 + T cells. As a consequence of the contact-mediated interaction with neutrophils, CD8 + T cells are skewed to produce high levels of GZMK, which in turn decreases E-cadherin on the intestinal epithelium and favors tumor progression.

Overall, our results highlight the emergence of GZMK high CD8 + T EM in non-metastatic CRC tumors as a hallmark driven by the interaction with neutrophils, which could implement current patient stratification and be targeted by novel therapeutics.

论文信息

作者
Tiberti S、Catozzi C、Croci O、Ballerini M、Cagnina D、Soriani C、Scirgolea C、Gong Z
第一作者单位
Department of Experimental Oncology, European Institute of Oncology- IRCCS, Milano, Italy.Italy
通讯作者单位
Department of Experimental Oncology, European Institute of Oncology- IRCCS, Milano, Italy. teresa.manzo@ieo.it.Italy
文献类型
非美国政府资助研究
期刊
Nature communications2022 Nov 8
原文标识
PubMed 36347862 · DOI 10.1038/s41467-022-34467-3